Abstract:The recovery of impaired periodontium is still a challenge to the treatment of periodontitis. This study was the first to apply the mesoporous hydroxyapatites/chitosan (mHA/CS) composite scaffold to periodontal regeneration. The aim of our study is to evaluate the biological effects of mesoporous hydroxyapatite/chitosan (mHA/CS) loaded with recombinant human amelogenin (rhAm) on periodontal regeneration. The physicochemical properties of mHA/CS scaffolds were examined by Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), and Brunauer-Emmett-Teller (BET) analysis. Then, the biological effects of the mHA/CS loaded with rhAm were evaluated, including antibacterial effect, controlled-release capacity, osteogenic and cementogenic effectsin vitroandin vivo. The antibacterial effect was tested on 1.5 mg/mL CS; 3 mg/mL mHA; 2.25 mg/mL mHA/CS; 4.5 mg/mL mHA/CS and 20 mu g/mL rhAm. Tryptic Soy Broth culture medium was used as a baseline control. Osteogenic effect of rhAm (20 mu g/mL rhAm), mHA/CS (4.5 mg/mL mHA/CS), and mHA/CS-rhAm (4.5 mg/mL mHA/CS and 20 mu g/mL rhAm) on human periodontal ligament cells (hPDLCs) was evaluated in osteogenic media. The hPDLCs treated either with osteogenic media or Dulbecco's modified Eagle's medium (DMEM) alone were used as the baseline control. In the animal model, 4-week-old nude mice (BALB/c) (n= 6) implanted with root slices subcutaneously were used to observe the cementogenic effectin vivo. The root slices were treated with rhAm (20 mu g/mL rhAm), mHA/CS (4.5 mg/mL mHA/CS), and mHA/CS-rhAm (4.5 mg/mL mHA/CS and 20 mu g/mL rhAm). The root slices treated with osteogenic medium alone were used as the baseline control. The analyses showed that the mHA/CS particles were 2 mu m in diameter and had a uniform pore size. The mesoporous structure was 7 nm in diameter and its surface area was 33.95 m(2)/g. The scaffold exhibited antibacterial effects againstFusobacterium nucleatumandPorphyromonas gingivalis. The mHA/CS scaffold sustainably released rhAm. The mHA/CS loaded with 20 mu g/mL rhAm upregulated ALP activity, the expression levels of osteogenesis-related genes and proteinsin vitro. Additionally, it promoted the formation of cementum-like tissuein vivo. Our findings suggest that mHA/CS loaded with 20 mu g/mL rhAm could inhibit the growth of periodontal pathogens and promote the formation of bone and cementum-like tissue.

Research Advance of Recombinant Amelogenin

Periodontal Regeneration by Gene Therapy

Research progress of emdogain in the field of stomatology

Re-understanding the Role of Enamel Matrix Proteins in Periodontal Regeneration

Healing of intrabony defects using a novel human recombinant amelogenin: a preclinical study

Different Effects of 25-Kda Amelogenin on the Proliferation, Attachment and Migration of Various Periodontal Cells

Analogous effects of recombinant human full-length amelogenin expressed by Pichia pastoris yeast and enamel matrix derivative in vitro.

A photoresponsive recombinant human amelogenin‐loaded hyaluronic acid hydrogel promotes bone regeneration

Experimental Study on Human Periodontal Ligament Cells Transfected with Human Amelogenin Gene

Recombinant Human Amelogenin Reverses Osteogenesis Suppression Induced By An Inflammatory Microenvironment In Human Periodontal Ligament Cells

[The Effect of Rham and EMPs on Promoting Differentiation of Hbmscs into Osteoblasts].

Mechanism of Enamel Matrix Proteins Enhancing Periodontal Regeneration

Mesoporous Hydroxyapatite/Chitosan Loaded With Recombinant-Human Amelogenin Could Enhance Antibacterial Effect and Promote Periodontal Regeneration

Mesoporous Hydroxyapatite/Chitosan Loaded With Recombinant-Human Amelogenin Could Enhance Antibacterial Effect and Promote Periodontal Regeneration.

Human Amelogenin Up-Regulates Osteogenic Gene Expression in Human Bone Marrow Stroma Cells.

In vivo Application of Amelogenin Suppresses Root Resorption

Recombinant human amelogenin promotes wound healing by enhancing angiogenesis

Amniotic Membrane: An Approach to Periodontal Regeneration

Human recombinant amelogenin acquirement by using eukaryocyte expression system

Differential effect of amelogenin peptides on osteogenic differentiation in vitro: identification of possible new drugs for bone repair and regeneration

Sustained delivery of chemically modified mRNA encoding amelogenin from self-assembling hydrogels for periodontal regeneration